An agent that causes an increase in the expansion of a bronchus or bronchial tubes.
Member | Definition | Class |
aclidinium bromide | A quaternary ammonium salt that is the bromide salt of aclidinium. A muscarinic acetylcholine M3 receptor antagonist, for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). | aclidinium bromide |
albuterol | A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). | albuterol |
aminophylline | A mixture comprising of theophylline and ethylenediamine in a 2:1 ratio. | aminophylline |
arformoterol | An N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide in which both of the stereocentres have R configuration. The active enantiomer of formoterol, it is administered by inhalation (generally as the tartrate salt) as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema). | arformoterol |
azelastine | A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position. | azelastine |
azelastine hydrochloride | The hydrochloride salt of azelastine. | azelastine hydrochloride |
bambuterol | A carbamate ester that is terbutaline in which both of the phenolic hydroxy groups have been protected as the corresponding N,N-dimethylcarbamates. A long acting beta-adrenoceptor agonist used in the treatment of asthma, it is a prodrug for terbutaline. | bambuterol |
bambuterol hydrochloride | The hydrochloride salt of bambuterol. A long acting beta-adrenoceptor agonist used in the treatment of asthma, it is a prodrug for terbutaline. | bambuterol hydrochloride |
berotek | A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction. | fenoterol |
bitolterol | The di-4-toluate ester of (+-)-N-tert-butylnoradrenaline (colterol). A pro-drug for colterol, a beta2-adrenergic receptor agonist, bitolterol is used as its methanesulfonate salt for relief of bronchospasm in conditions such as asthma, chronic bronchitis and emphysema. | bitolterol |
cilostazol | A lactam that is 3,4-dihydroquinolin-2(1H)-one in which the hydrogen at position 6 is substituted by a 4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy group. | cilostazol |
clenbuterol | A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group. | clenbuterol |
colterol | A member of the class of ethanolamines that is catechol in which the hydrogen at position 4 is replaced by a 2-(tert-butylamino)-1-hydroxyethyl group. | colterol |
diazoxide | A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. | diazoxide |
diphemanil methylsulfate | The alkene resulting from the formal Wittig olefination of benzophenone and 1,1-dimethyl-4-bromopiperidinium methylsulfate. A quaternary ammonium anticholinergic, it binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stomach acids, saliva and sweat, It is used topically in the treatment of hyperhidorsis (excessive sweating). | diphemanil methylsulfate |
doxofylline | An oxopurine that is a derivative of xanthine, methylated at N-1 and N-3 and carrying a 1,3-dioxolan-2-ylmethyl group at N-7, used in the treatment of asthma. | doxofylline |
dyphylline | An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs. | dyphylline |
enprofylline | Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. | enprofylline |
fenoterol | The hydrobromide salt of fenoterol. A beta2-adrenergic agonist, it is used as a bronchodilator in the management of reversible airway obstruction. | fenoterol hydrobromide |
fluticasone propionate | A trifluorinated corticosteroid that consists of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a propionyl substituent at position 17; has anti-inflammatory, anti-asthmatic and anti-allergic activity. | fluticasone propionate |
indacaterol | A monohydroxyquinoline that consists of 5-[(1R)-2-amino-1-hydroxyethyl]-8-hydroxyquinolin-2-one having a 5,6-diethylindan-2-yl group attached to the amino function. Used as the maleate salt for treatment of chronic obstructive pulmonary disease. | indacaterol |
isoproterenol | A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders. | isoprenaline |
khellin | A furanochrome in which the basic tricyclic skeleton is substituted at positions 4 and 9 with methoxy groups and at position 7 with a methyl group. A major constituent of the plant Ammi visnaga it is a herbal folk medicine used for various illnesses, its main effect being as a vasodilator. | khellin |
methoxyphenamine | An amphetamine methylated on nitrogen and with the phenyl ring methoxylated at C-2. A beta-adrenergic receptor agonist, it is used as a bronchodilator. | methoxyphenamine |
nab-365 | A hydrochloride that is the monohydrochloride salt of clenbuterol. | clenbuterol hydrochloride |
olodaterol | A member of the class of benzoxazine that is 6-hydroxy-1,4-benzoxazin-3-one in which the hydrogen at position 4 is replaced by a (1R)-1-hydroxy-2-{[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino}ethyl group. Used (as its hydrochloride salt) for long-term treatment of airflow obstruction in patients with chronic obstructive pulmonary disease including chronic bronchitis and/or emphysema. | olodaterol |
pseudoephedrine | A member of the class of the class of phenylethanolamines that is (1S)-2-(methylamino)-1-phenylethan-1-ol in which the pro-S hydrogen at position 2 is replaced by a methyl group. | pseudoephedrine |
pulmicort | A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis. | budesonide |
rp 73401 | A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 3-(cyclopentyloxy)-4-methoxybenzoic acid with the primary amino group of 3,5-dichloropyridin-4-amine. | piclamilast |
s-nitrosoglutathione | A glutathione derivative that is glutathione in which the hydrogen attached to the sulfur has been replaced by a nitroso group. | S-nitrosoglutathione |
terbutaline | A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group. | terbutaline |
theobromine | A dimethylxanthine having the two methyl groups located at positions 3 and 7. A purine alkaloid derived from the cacao plant, it is found in chocolate, as well as in a number of other foods, and is a vasodilator, diuretic and heart stimulator. | theobromine |
theophylline | A dimethylxanthine having the two methyl groups located at positions 1 and 3. It is structurally similar to caffeine and is found in green and black tea. | theophylline |
vilanterol | An dichlorobenzene derivative that is used in the form of its trifenate salt for treatment of chronic obstructive pulmonary disease. | vilanterol |
zardaverine | A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4. | zardaverine |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 18.4802 | 1 | 6 |
15-lipoxygenase, partial | Homo sapiens (human) | Potency | 0.3981 | 1 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Leishmania major strain Friedlin | Potency | 23.9341 | 1 | 1 |
67.9K protein | Vaccinia virus | Potency | 15.8489 | 1 | 1 |
acetylcholinesterase | Homo sapiens (human) | Potency | 22.8333 | 3 | 5 |
activating transcription factor 6 | Homo sapiens (human) | Potency | 13.3256 | 1 | 3 |
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 14.4146 | 1 | 6 |
alpha-galactosidase | Homo sapiens (human) | Potency | 32.4648 | 2 | 2 |
Alpha-synuclein | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 1.7783 | 1 | 1 |
AR protein | Homo sapiens (human) | Potency | 7.7955 | 10 | 38 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 3.6182 | 2 | 5 |
arylsulfatase A | Homo sapiens (human) | Potency | 16.9188 | 1 | 5 |
ATAD5 protein, partial | Homo sapiens (human) | Potency | 1.8349 | 1 | 1 |
Ataxin-2 | Homo sapiens (human) | Potency | 6.2874 | 1 | 4 |
ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 10.7062 | 2 | 10 |
ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 6.7868 | 2 | 6 |
beta-2 adrenergic receptor | Homo sapiens (human) | Potency | 6.4678 | 4 | 8 |
Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 0.1022 | 2 | 6 |
bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 42.2044 | 1 | 3 |
caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 33.4915 | 1 | 1 |
Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 33.4915 | 1 | 1 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 7.4697 | 1 | 6 |
cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 29.0253 | 2 | 6 |
Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 0.2239 | 1 | 1 |
Chain A, HADH2 protein | Homo sapiens (human) | Potency | 10.0371 | 2 | 4 |
Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 8.9125 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 10.1323 | 1 | 4 |
Chain B, HADH2 protein | Homo sapiens (human) | Potency | 10.0371 | 2 | 4 |
chromobox protein homolog 1 | Homo sapiens (human) | Potency | 63.3839 | 2 | 9 |
cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 7.4819 | 1 | 3 |
cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 13.8683 | 1 | 3 |
cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 14.3022 | 1 | 7 |
cytochrome P450 2D6 | Homo sapiens (human) | Potency | 16.1908 | 1 | 11 |
cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 10.1775 | 1 | 3 |
cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 15.0378 | 2 | 25 |
cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 6.3578 | 2 | 13 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 0.0024 | 1 | 3 |
D(1A) dopamine receptor | Homo sapiens (human) | Potency | 1.2995 | 1 | 1 |
D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 18.4927 | 1 | 1 |
DNA polymerase beta | Homo sapiens (human) | Potency | 100.0000 | 1 | 1 |
DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 47.7117 | 1 | 3 |
DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 16.8336 | 1 | 1 |
endonuclease IV | Escherichia coli | Potency | 12.5893 | 1 | 1 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 22.8218 | 8 | 29 |
estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 44.9200 | 2 | 4 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 17.1867 | 9 | 40 |
euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 17.0455 | 1 | 15 |
EWS/FLI fusion protein | Homo sapiens (human) | Potency | 15.1804 | 4 | 18 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 8.4587 | 2 | 2 |
flap endonuclease 1 | Homo sapiens (human) | Potency | 8.4368 | 1 | 1 |
Fumarate hydratase | Homo sapiens (human) | Potency | 33.1734 | 1 | 2 |
G | Vesicular stomatitis virus | Potency | 14.3022 | 1 | 7 |
GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
GALC protein | Homo sapiens (human) | Potency | 0.6310 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 14.4123 | 1 | 14 |
geminin | Homo sapiens (human) | Potency | 10.1126 | 2 | 17 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 9.2969 | 2 | 12 |
glp-1 receptor, partial | Homo sapiens (human) | Potency | 4.8721 | 4 | 12 |
GLS protein | Homo sapiens (human) | Potency | 10.8740 | 2 | 13 |
glucocerebrosidase | Homo sapiens (human) | Potency | 31.0990 | 1 | 2 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 3.2343 | 3 | 14 |
glucokinase regulatory protein | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 42.9327 | 1 | 4 |
GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 9.3805 | 1 | 3 |
Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 7.7705 | 1 | 3 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | Homo sapiens (human) | Potency | 7.9433 | 1 | 1 |
hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 11.6350 | 2 | 13 |
histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 26.6459 | 1 | 3 |
Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 54.2859 | 2 | 3 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 14.3022 | 1 | 7 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 1.5816 | 2 | 4 |
IDH1 | Homo sapiens (human) | Potency | 12.8848 | 1 | 2 |
importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 14.9411 | 2 | 4 |
Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 14.3022 | 1 | 14 |
Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 7.9433 | 1 | 1 |
Interferon beta | Homo sapiens (human) | Potency | 14.0067 | 2 | 10 |
lamin isoform A-delta10 | Homo sapiens (human) | Potency | 3.3295 | 2 | 12 |
lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 4.4654 | 1 | 3 |
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 39.8107 | 1 | 1 |
M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 22.8342 | 1 | 2 |
Microtubule-associated protein tau | Homo sapiens (human) | Potency | 7.9433 | 1 | 2 |
mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 6.5772 | 2 | 6 |
muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 44.5682 | 2 | 2 |
neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 13.1311 | 1 | 2 |
NFKB1 protein, partial | Homo sapiens (human) | Potency | 14.1200 | 2 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 34.2059 | 2 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 20.5962 | 1 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 43.6465 | 1 | 1 |
Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 42.1632 | 1 | 1 |
nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 10.3769 | 2 | 6 |
nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 7.0871 | 1 | 2 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 15.6027 | 3 | 17 |
Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 7.9433 | 1 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 34.6989 | 1 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 37.9330 | 1 | 1 |
peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 10.8610 | 1 | 9 |
peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 81.8430 | 1 | 3 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 57.3148 | 2 | 2 |
peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 19.0625 | 2 | 3 |
phosphopantetheinyl transferase | Bacillus subtilis | Potency | 66.1507 | 1 | 4 |
plasminogen precursor | Mus musculus (house mouse) | Potency | 11.2202 | 1 | 1 |
polyprotein | Zika virus | Potency | 33.1734 | 1 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 3.1623 | 1 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 6.6102 | 1 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 10.2310 | 1 | 3 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 23.3106 | 2 | 11 |
progesterone receptor | Homo sapiens (human) | Potency | 0.0071 | 2 | 6 |
pyruvate kinase | Leishmania mexicana mexicana | Potency | 10.0000 | 2 | 2 |
pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 7.9433 | 2 | 2 |
Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 11.2202 | 1 | 1 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 26.0126 | 2 | 10 |
regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 16.5369 | 1 | 9 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 28.5312 | 3 | 15 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 20.6080 | 3 | 16 |
RGS12 | Homo sapiens (human) | Potency | 7.9433 | 1 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 15.7922 | 2 | 2 |
serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 22.4852 | 1 | 2 |
SMAD family member 2 | Homo sapiens (human) | Potency | 22.0950 | 2 | 7 |
SMAD family member 3 | Homo sapiens (human) | Potency | 22.0950 | 2 | 7 |
Smad3 | Homo sapiens (human) | Potency | 0.7079 | 1 | 1 |
snurportin-1 | Homo sapiens (human) | Potency | 14.9411 | 2 | 4 |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 27.7232 | 1 | 3 |
survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 10.8875 | 1 | 10 |
TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 23.3507 | 1 | 2 |
TDP1 protein | Homo sapiens (human) | Potency | 20.9908 | 2 | 20 |
thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 10.1827 | 4 | 14 |
Thrombopoietin | Homo sapiens (human) | Potency | 6.3404 | 2 | 6 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 39.3494 | 3 | 9 |
thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 6.3096 | 1 | 1 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 8.7616 | 7 | 34 |
transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 20.2057 | 1 | 4 |
urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 11.2202 | 1 | 1 |
urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 11.2202 | 1 | 1 |
USP1 protein, partial | Homo sapiens (human) | Potency | 30.4570 | 2 | 7 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 20.0812 | 2 | 9 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 14.4394 | 2 | 3 |
vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 79.4328 | 1 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 42.9327 | 1 | 4 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
10 kDa chaperonin | Escherichia coli | IC50 | 175.0000 | 2 | 2 |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
3',5'-cyclic-AMP phosphodiesterase | Sus scrofa (pig) | IC50 | 0.0010 | 1 | 1 |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 2.6520 | 1 | 1 |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 86.0000 | 1 | 1 |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 1.5150 | 1 | 1 |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 2.6520 | 1 | 1 |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 1.5150 | 1 | 1 |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.0200 | 1 | 1 |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 0.5012 | 1 | 1 |
60 kDa chaperonin | Escherichia coli K-12 | IC50 | 250.0000 | 1 | 1 |
60 kDa chaperonin | Escherichia coli | IC50 | 175.0000 | 2 | 2 |
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 100.0000 | 1 | 1 |
Acetylcholinesterase | Homo sapiens (human) | IC50 | 25.0000 | 4 | 4 |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | IC50 | 30.0000 | 1 | 1 |
Adenosine receptor A1 | Bos taurus (cattle) | IC50 | 1,006,650,005.0433 | 3 | 3 |
Adenosine receptor A1 | Homo sapiens (human) | IC50 | 17.1040 | 1 | 1 |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | IC50 | 19.0000 | 2 | 2 |
Adenosine receptor A1 | Bos taurus (cattle) | Ki | 4.1143 | 7 | 7 |
Adenosine receptor A1 | Cavia porcellus (domestic guinea pig) | Ki | 21.3333 | 6 | 6 |
Adenosine receptor A1 | Gallus gallus (chicken) | Ki | 6.0000 | 1 | 1 |
Adenosine receptor A1 | Homo sapiens (human) | Ki | 10.2759 | 18 | 20 |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Ki | 18.0559 | 31 | 41 |
Adenosine receptor A2a | Homo sapiens (human) | IC50 | 12.0070 | 1 | 1 |
Adenosine receptor A2a | Cavia porcellus (domestic guinea pig) | Ki | 14.0000 | 2 | 2 |
Adenosine receptor A2a | Homo sapiens (human) | Ki | 17.7950 | 27 | 32 |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 47.4980 | 24 | 40 |
Adenosine receptor A2b | Homo sapiens (human) | Ki | 16.8692 | 20 | 26 |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | Ki | 54.4484 | 18 | 32 |
Adenosine receptor A3 | Homo sapiens (human) | Ki | 61.2688 | 20 | 22 |
Adenosine receptor A3 | Rattus norvegicus (Norway rat) | Ki | 47.3650 | 8 | 10 |
Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens (human) | IC50 | 52.5000 | 2 | 2 |
Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens (human) | Ki | 82.0000 | 1 | 1 |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
Alpha-1A adrenergic receptor | Homo sapiens (human) | Ki | 0.0501 | 3 | 3 |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 17.7751 | 2 | 2 |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
Alpha-1B adrenergic receptor | Homo sapiens (human) | Ki | 0.0501 | 3 | 3 |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 35.5000 | 1 | 1 |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 35.5000 | 1 | 1 |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 21.0000 | 1 | 1 |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 21.0000 | 1 | 1 |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 21.0000 | 1 | 1 |
Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 4.1150 | 2 | 3 |
Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 1.0900 | 1 | 1 |
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 123.1875 | 1 | 8 |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | IC50 | 470.5000 | 4 | 4 |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 23.0000 | 2 | 2 |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | IC50 | 470.5000 | 4 | 4 |
Beta-1 adrenergic receptor | Homo sapiens (human) | IC50 | 0.2564 | 2 | 3 |
Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.2125 | 2 | 2 |
Beta-1 adrenergic receptor | Homo sapiens (human) | Ki | 0.4059 | 4 | 5 |
Beta-1 adrenergic receptor | Mus musculus (house mouse) | Ki | 0.2200 | 1 | 1 |
Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.3750 | 2 | 2 |
Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | IC50 | 0.6667 | 2 | 3 |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.0340 | 2 | 2 |
Beta-2 adrenergic receptor | Homo sapiens (human) | IC50 | 0.8954 | 3 | 6 |
Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.2125 | 2 | 2 |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.9520 | 1 | 2 |
Beta-2 adrenergic receptor | Homo sapiens (human) | Ki | 0.3552 | 12 | 17 |
Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.6761 | 1 | 1 |
Beta-2 adrenergic receptor | Bos taurus (cattle) | Ki | 0.1100 | 2 | 2 |
Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.2125 | 2 | 2 |
Beta-3 adrenergic receptor | Homo sapiens (human) | Ki | 18.6209 | 1 | 1 |
Bile salt export pump | Homo sapiens (human) | IC50 | 493.0632 | 5 | 19 |
Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Homo sapiens (human) | IC50 | 660.0000 | 2 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Bos taurus (cattle) | IC50 | 285.3333 | 6 | 6 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Bos taurus (cattle) | IC50 | 242.4000 | 5 | 5 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | IC50 | 122.0782 | 3 | 22 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | IC50 | 660.0000 | 2 | 2 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Homo sapiens (human) | IC50 | 68.2860 | 1 | 20 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | IC50 | 95.7693 | 22 | 24 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | IC50 | 0.2100 | 1 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | Ki | 75.7152 | 7 | 7 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | Ki | 265.0130 | 2 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | IC50 | 69.5919 | 29 | 50 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | IC50 | 0.2100 | 1 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | Ki | 75.7152 | 7 | 7 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | Ki | 265.0130 | 2 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | IC50 | 83.1511 | 21 | 23 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | IC50 | 0.2100 | 1 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | Ki | 75.7152 | 7 | 7 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | Ki | 265.0130 | 2 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 60.4163 | 30 | 56 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | Ki | 75.7152 | 7 | 7 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | IC50 | 0.2100 | 1 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | Ki | 265.0130 | 2 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | Homo sapiens (human) | IC50 | 68.2860 | 1 | 20 |
Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 8 |
Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | IC50 | 0.0030 | 1 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | IC50 | 69.8633 | 3 | 24 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | IC50 | 54.1739 | 11 | 13 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | IC50 | 67.8958 | 10 | 29 |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | IC50 | 61.5300 | 3 | 24 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | IC50 | 0.1300 | 1 | 21 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 0.1300 | 1 | 12 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | IC50 | 0.1300 | 1 | 6 |
Chain A, Phosphodiesterase 4D | Homo sapiens (human) | IC50 | 0.1600 | 1 | 1 |
Chain A, Pyridoxal kinase | Homo sapiens (human) | Ki | 50.0000 | 1 | 2 |
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | IC50 | 0.1300 | 1 | 3 |
Chitotriosidase-1 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 2 |
Cholinesterase | Equus caballus (horse) | IC50 | 0.1193 | 1 | 1 |
Cholinesterase | Homo sapiens (human) | IC50 | 0.0033 | 4 | 4 |
Coagulation factor VII | Homo sapiens (human) | IC50 | 740.0000 | 1 | 1 |
Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 4.0200 | 1 | 1 |
Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 3.8000 | 1 | 1 |
Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 0.0400 | 1 | 1 |
Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 0.0310 | 1 | 1 |
Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 46.9000 | 2 | 2 |
Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 10.0000 | 2 | 2 |
Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 4.3333 | 3 | 3 |
Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 0.0501 | 1 | 1 |
Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 0.0200 | 1 | 1 |
D(1A) dopamine receptor | Homo sapiens (human) | Ki | 50.0000 | 1 | 1 |
D(2) dopamine receptor | Homo sapiens (human) | Ki | 30.0000 | 2 | 2 |
D(3) dopamine receptor | Homo sapiens (human) | Ki | 2.8740 | 2 | 2 |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.0006 | 1 | 1 |
D(4) dopamine receptor | Homo sapiens (human) | Ki | 2.9000 | 1 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | Homo sapiens (human) | IC50 | 68.2860 | 1 | 20 |
Endochitinase B1 | Aspergillus fumigatus | IC50 | 1,000.0000 | 1 | 2 |
Endothelin-1 receptor | Sus scrofa (pig) | IC50 | 0.0010 | 1 | 1 |
Estrogen receptor | Homo sapiens (human) | IC50 | 10.0000 | 1 | 2 |
Estrogen receptor beta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 2 |
Glucocorticoid receptor | Homo sapiens (human) | IC50 | 0.0013 | 6 | 9 |
Glucocorticoid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0027 | 2 | 3 |
Glucocorticoid receptor | Homo sapiens (human) | Ki | 0.0017 | 2 | 2 |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | IC50 | 63.7704 | 2 | 23 |
high affinity choline transporter 1 isoform a | Homo sapiens (human) | IC50 | 0.0078 | 2 | 4 |
Histamine H1 receptor | Homo sapiens (human) | Ki | 0.0012 | 3 | 3 |
Histamine H3 receptor | Homo sapiens (human) | Ki | 0.1514 | 3 | 3 |
Interleukin-5 | Homo sapiens (human) | IC50 | 26.8000 | 1 | 1 |
Interleukin-5 | Mus musculus (house mouse) | IC50 | 26.5375 | 8 | 8 |
Interleukin-5 receptor subunit alpha | Mus musculus (house mouse) | IC50 | 26.2000 | 1 | 1 |
Intestinal-type alkaline phosphatase | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
Matrix metalloproteinase-9 | Homo sapiens (human) | IC50 | 1.9890 | 1 | 1 |
Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 0.0815 | 1 | 2 |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 106.2000 | 1 | 8 |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 2.1033 | 3 | 3 |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 0.0001 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 0.0001 | 3 | 3 |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 0.0003 | 2 | 2 |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | IC50 | 0.0001 | 4 | 4 |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | Ki | 0.0003 | 2 | 2 |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | IC50 | 2,904.0000 | 1 | 1 |
Phosphodiesterase | Bos taurus (cattle) | IC50 | 250.3333 | 6 | 6 |
Phosphodiesterase | Bos taurus (cattle) | Ki | 77.0000 | 1 | 1 |
Phospholipase A-2-activating protein | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 1.7700 | 1 | 1 |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 0.1000 | 4 | 4 |
Progesterone receptor | Homo sapiens (human) | IC50 | 0.0245 | 1 | 2 |
Renin | Homo sapiens (human) | Ki | 2.3250 | 1 | 2 |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 100.0000 | 1 | 1 |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 100.0000 | 1 | 1 |
Serine/arginine-rich splicing factor 6 | Homo sapiens (human) | IC50 | 19.0100 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | Ki | 7.9000 | 1 | 1 |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 27.1000 | 1 | 1 |
Testosterone 17-beta-dehydrogenase 3 | Rattus norvegicus (Norway rat) | IC50 | 0.0001 | 1 | 1 |
Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | Ki | 14.0000 | 1 | 1 |
Tissue factor | Homo sapiens (human) | IC50 | 740.0000 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 91.2000 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 91.2000 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 91.2000 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 91.2000 | 1 | 1 |